Based on data retrieved from China’s National Medical Products Administration (NMPA), seven new cosmetic ingredients have been filed between January 15 and February 3, 2026. Detailed information is provided in the table below. At present, the associated technical specifications have not been made public, and the ingredient has not yet entered the post-filing monitoring period. As of now in 2026, a total of 20 new cosmetic ingredients have been filed. Among them, 19 were filed in January, representing a 90% year-on-year increase compared to 10 in the same period in 2025.
| Filing Number | Standard Chinese Name | Filing Date | Chinese Name for the Filer | Filer Location |
| 国妆原备字20260016 | 甘草亭酸葡糖醛酸苷 | 2026/1/26 | Zhejiang Huarui Biotechnology Co., Ltd. | Domestic China |
| 国妆原备字20260017 | α-丁酮酸钠 | 2026/1/27 | Yunnan Botanee Bio-Technology Group Co., Ltd. | Domestic China |
| 国妆原备字20260018 | β-烟酰胺单核苷酸 | 2026/1/27 | Nanjing Nuoyun Biotechnology Co., Ltd. | Domestic China |
| 国妆原备字20260019 | s-蜜蜂寡肽-1 | 2026/1/29 | Nuoweitai (Kunming) Biotechnology Co., Ltd. | Domestic China |
| 国妆原备字20260020 | 青春双歧杆菌(BIFIDOBACTERIUM ADOLESCENTIS)/阔孢块菌（TUBER LATISPORUM）发酵产物滤液 | 2026/2/3 | 时垠（上海）生物科技有限公司 | Domestic China |
Note: The English names of the companies listed above located in domestic China are for reference only. Please refer to the official registered or commonly used names for formal use.
Interpretation of Information on New Cosmetic Ingredient
Glycyrrhiza uralensis Fisch, a perennial herbaceous plant in the legume family (Fabaceae), is traditionally known in classical Chinese medicine as the “State Elder” (Guolao). It is believed to “neutralize hundreds of toxins, harmonize various medicines, and replenish Qi deficiency.” As a key ingredient in traditional Chinese medicine (TCM) compound formulations, it plays a crucial role in balancing medicinal properties and enhancing therapeutic efficacy.
Huarui Biotechnology utilizes enzyme-directed catalytic conversion technology to achieve an efficient and environmentally friendly transformation of glycyrrhizic acid into glycyrrhetinic acid glucuronide.
β-Nicotinamide Mononucleotide (INCI name: Nicotinamide Mononucleotide, NMN) is a naturally occurring bioactive nucleotide composed of ribose, a nicotinamide moiety, and a phosphate group. NMN exists in two isomeric forms—α and β—with the β-form being the biologically active one. In the human body, β-NMN directly participates in the biosynthesis of the coenzyme nicotinamide adenine dinucleotide (NAD⁺) and exerts its biological functions through NAD⁺.
CIRS Group has launched Global CosIng – A One-Stop Search Tool for Global Cosmetic Compliance Information. You can visit Global CosIng and find out more via the following link: https://globalcosing.chemradar.com/
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.
Our Services
- China Cosmetics Registration and Filing
- China New Cosmetic Ingredients Registration and Filing
- China Toothpaste Filing
- China Cosmetics Safety and Efficacy Test
- Being a Domestic Responsible Person
- Safety Evaluation Report
- Cosmetic Ingredient Quality and Safety Info Code Application
- Formula/Label/Ingredient Review
- Regulatory Consulting/Reporting/Training
- Custom Clearance
